Register for long-term observation of participants in cancer studies

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038176

Enrollment

15000

Registered

2025-10-23

Start date

2026-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer C50

Interventions

Group 1: Semi-annual survey on health status, new illnesses, possible pregnancy, quality of life, and relevant side effects

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Participation in a clinical cancer trial. Provision of written informed consent.

Exclusion criteria

Exclusion criteria: History of significant neurological or psychiatric disorders that would prohibit the understanding of the study purpose and giving informed consent.

Design outcomes

Primary

Measure	Time frame
Overall and Disease-free survival	—

Secondary

Measure	Time frame
• Long-term toxicity associated with study therapy. • Subsequent anti-cancer therapies administered after study completion. • Pregnancies occurring after study participation and evaluate their outcomes. • Quality of life (QoL) post-study. • Additional study-specific long-term outcomes as defined in the respective study protocol	—

Countries

Austria, Germany, Switzerland

Contacts

Public ContactSibylle Loibl

GBG Forschungs GmbH

Sibylle.Loibl@GBG.de+49 6102 / 7480-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026